These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 29692979)

  • 21. Agreement Among Different Scales for Causality Assessment in Drug-Induced Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.
    Sivagourounadin K; Rajendran P; Selvarajan S; Ganesapandian M
    Curr Drug Saf; 2022; 17(1):40-46. PubMed ID: 34126908
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development and inter-rater reliability of the Liverpool adverse drug reaction causality assessment tool.
    Gallagher RM; Kirkham JJ; Mason JR; Bird KA; Williamson PR; Nunn AJ; Turner MA; Smyth RL; Pirmohamed M
    PLoS One; 2011; 6(12):e28096. PubMed ID: 22194808
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Accuracy in patient-reported adverse drug reactions and their recognition: a mixed-methods study.
    Kampichit S; Srisuriyachanchai W; Pratipanawatr T; Jarernsiripornkul N
    Int J Clin Pharm; 2024 Apr; 46(2):401-410. PubMed ID: 38151687
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An analysis of serious adverse drug reactions at a tertiary care teaching hospital.
    Prajapati K; Desai M; Shah S; Panchal J; Kapadia J; Dikshit R
    Perspect Clin Res; 2016; 7(4):181-186. PubMed ID: 27843794
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of three algorithms used to evaluate adverse drug reactions.
    Michel DJ; Knodel LC
    Am J Hosp Pharm; 1986 Jul; 43(7):1709-14. PubMed ID: 3752106
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacovigilance Study of Anticancer Drugs in a Tertiary Care Teaching Hospital in North India: A Retrospective Study.
    Kumar R; Jindal A; Garg P; Kaur A; Kumar S; Tilak Raj R; Singh S
    Cureus; 2023 Sep; 15(9):e44984. PubMed ID: 37822427
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of naranjo adverse drug reactions probability scale in causality assessment of drug-induced liver injury.
    García-Cortés M; Lucena MI; Pachkoria K; Borraz Y; Hidalgo R; Andrade RJ;
    Aliment Pharmacol Ther; 2008 May; 27(9):780-9. PubMed ID: 18284654
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adverse Drug Reaction Profile of Anticancer Agents in a Tertiary Care Hospital: An Observational Study.
    Shaikh SP; Nerurkar R
    Curr Drug Saf; 2022; 17(2):136-142. PubMed ID: 34433404
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exploration and Evaluation of Adverse Drug Reactions Documented in a Tertiary-Care Hospital in Chennai: An In-Depth Retrospective Observational Study.
    Selva P; Durairajan S
    Cureus; 2024 May; 16(5):e60977. PubMed ID: 38915954
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of Cutaneous Adverse Drug Reactions (ADR) Reported at an ADR Monitoring Center of a Tertiary Care Teaching Institute in Central India.
    Chindhalore CA; Gupta AV; Dakhale GN; Srivastava A
    Cureus; 2024 Feb; 16(2):e53706. PubMed ID: 38455795
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Prospective Study of Adverse Drug Reactions in Patients with Bipolar Disorder in Psychiatry Outpatient Department of a Tertiary Care Hospital.
    Shah A; Yadav PP; Chaudhari M; Vataliya A; Kantharia ND; Mehta R
    J Clin Diagn Res; 2017 May; 11(5):FC24-FC28. PubMed ID: 28658799
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A tailor-made approach for causality assessment for ADR reports on drugs and vaccines.
    Oosterhuis I; Zweers P; Rümke H; Muller-Hansma A; van Puijenbroek EP
    Pharmacoepidemiol Drug Saf; 2019 Apr; 28(4):544-550. PubMed ID: 30168222
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adverse drug reaction profile of cisplatin-based chemotherapy regimen in a tertiary care hospital in India: An evaluative study.
    Surendiran A; Balamurugan N; Gunaseelan K; Akhtar S; Reddy KS; Adithan C
    Indian J Pharmacol; 2010 Feb; 42(1):40-3. PubMed ID: 20606836
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A cross-sectional study of surveillance of adverse drug reactions in inpatient departments of a tertiary care hospital.
    Remesh A; Balan A; Gnanadurai A
    J Basic Clin Physiol Pharmacol; 2014 Feb; 25(1):125-30. PubMed ID: 24423467
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adverse Cutaneous Drug Reactions at a Rural-Based Tertiary Health-Care Center in Gujarat: An Eleven Year Study.
    Vora RV; Patel TB; Tandel JJ; Patel JK; Polra RV
    Indian Dermatol Online J; 2023; 14(1):50-54. PubMed ID: 36776185
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patterns of Adverse Drug Reaction in the Medical Wards of a Teaching Hospital: A Prospective Observational Cohort Study.
    Peter JV; Varghese GH; Alexander H; Tom NR; Swethalekshmi V; Truman C; Kumar TR; Sivakumar T
    Curr Drug Saf; 2016; 11(2):164-71. PubMed ID: 26916785
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adverse drug reactions to anti-diabetic drugs are commonest in patients whose treatment do not adhere to diabetes management clinical guidelines: cross-sectional study in a tertiary care service in sub-Saharan Africa.
    Elangwe A; Katte JC; Tchapmi D; Figueras A; Mbanya JC
    Eur J Clin Pharmacol; 2020 Nov; 76(11):1601-1605. PubMed ID: 32607780
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adverse drug reaction monitoring in a secondary care hospital in South India.
    Arulmani R; Rajendran SD; Suresh B
    Br J Clin Pharmacol; 2008 Feb; 65(2):210-6. PubMed ID: 17662089
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Initial development and testing of an instrument for patient self-assessment of adverse drug reactions.
    Jarernsiripornkul N; Chaipichit N; Pratipanawatr T; Uchaipichat V; Krska J
    Pharmacoepidemiol Drug Saf; 2016 Jan; 25(1):54-63. PubMed ID: 26349635
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Validation of a novel causality assessment scale for adverse events in non-small cell lung carcinoma patients treated with platinum and pemetrexed doublet chemotherapy.
    Sharma JB; Krishnamurthy MN; Awase A; Joshi A; Patil V; Noronha V; Prabhash K; Gota V
    Ther Adv Drug Saf; 2021; 12():2042098621991280. PubMed ID: 33628419
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.